: :  < Burnsurgery.org > : : 

Educating the burn care professionals around the world

Search Site  

HOME

 

 

 

 

 

 

 

 

 

 

 

 

AUTHORS: Robert H. Demling, M.D. Leslie DeSanti R.N. Dennis P. Orgill, M.D. Ph.D.

TRANSCYTE

 

D. CLINICAL USE IN PARTIAL THICKNESS BURNS AND EXCISED WOUNDS

Process of Application

 

Identify appropriate wound and clean surface

 

Thaw Transcyte and cut to fit wound, overlapping edges

 

Use of compression dressing for initial immobilization

 

 

 

Day 3: Adherence Excellent

 

Day 10: Healed

 


 

1) USE ON SUPERFICIAL MID PARTIAL THICKNESS BURNS

FACIAL BURN

Cleaned superficial mid dermal burn Adherence evident on day 1 after compression dressing removed
Day 5: opacity of membrane reflective of re-epithelialization

 


 

2) USE ON PARTIAL THICKNESS FOOT BURN

 

Admission

Day 1: note excellent adherence

Day 5: Opacity evident indicating healing

Day 16: Complete Healing

 


 

3) HAND BURNS

Use on palm burn. Good adherence at Day 1, Good Flexibility
Hand burn with Transcyte closure on Day 10: Note opacity reflecting healing
Day 16: Hand healed except for few patches on fingers

 


 

4) MID DERMAL FOOT BURN

Day 2: Good adherence and joint flexibility, Patient ambulating

 

Day 10: Note color change reflecting healing

 

5) BURN IN CHILD

 

Day 10: Transcyte in place, adhered over joint.
Note: opacity reflecting healing

 

Day 12: Majority of burn healed. Area over knee still requires a few more days

 


 

E.  EVIDENCE FOR EFFECTIVENESS

1) Partial Thickness Burns vs. Topical Agents

Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes)*

Robert H. Demling*, Leslie DeSanti

Trauma and Burn Center, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA

Abstract

This study compared the effect of standard topical antibiotic management versus a biological skin substitute wound closure for mid-partial thickness burns of the face. Adult patients with mid-dermal facial burns produced by flash flames or flame exposure were studied using a randomized prospective study design. Total daily burn care time, pain (0-10 scale) and healing time were monitored. Immediately after partial thickness debridement, the entire face burn, including ears, was closed with a bioengineered skin substitute coated with fibronectin (TransCyte) or treated by the open technique using bacitracin ointment applied 2-3 times daily. 21 patients were studied, with 10 patients in the skin substitute group. We found a significant decrease in wound care time 0.35± 0.1 versus 1.9± 0.5 h, decrease in pain of 2± 1 versus 4± 2 and re-epithelialization time 7± 2 versus 13± 4 days in the skin substitute group compared to topical antibiotics. We can conclude that a bioengineered skin substitute significantly improves the management and healing rate of partial thickness facial burns, compared to the standard open topical ointment technique. 

© 1999 Elsevier Science Ltd and ISBI. All rights reserved.

 

HEALING TIME AND PAIN CONTROL
(Transcyte vs. Topical Agents)

* Significantly different

Transcyte significantly decreased pain and increased rate of healing

 

Days to 90% Wound Re-epithelialization

  MEAN RANGE
DERMAGRAFT-TC 8.8 6-15
SILVER SULFADIAZINE 18.8 10-26
 

Hanbrough J. B Burn Care Rehab 1997: 18; 25.

 

 

 


© Copyright 2000 Burnsurgery.org. All Rights Reserved